Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial

Lancet Psychiatry. 2017 Mar 27. pii: S2215-0366(17)30077-9. DOI:10.1016/S2215-0366(17)30077-9 [Epub ahead of print]

Anderson IM, Blamire A, Branton T, Clark R, et al

https://www.ncbi.nlm.nih.gov/pubmed/28359862

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s